|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02496 YZYBIO-B
Nominal 
3.300 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (21,575) | (100,716) | (186,016) | (176,703) |
| Net Cash from / (used in) Investing Activities | -- | (130) | (4,668) | 54,807 | 5,804 |
| Net Cash from / (used in) Financing Activities | -- | (4,683) | 33,023 | 176,292 | 241,334 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (26,388) | (72,361) | 45,083 | 70,435 |
| Cash & Cash Equivalents at beginning of period | -- | 126,275 | 196,684 | 153,520 | 83,085 |
| Effect of Foreign Exchange Rate Changes | -- | 178 | 1,952 | (1,919) | 0 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 100,065 | 126,275 | 196,684 | 153,520 |
| Remarks: | Real time quote last updated: 10/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -6,260 |
| %Change | -89.360% |
| EPS / (LPS) | RMB -0.030 |
| NBV Per Share (¥) | RMB -0.302 |